Cargando…
Inhibition of glioblastoma cell proliferation, invasion, and mechanism of action of a novel hydroxamic acid hybrid molecule
Glioblastoma multiforme is one of the most aggressive brain tumors and current therapies with temozolomide or suberoylanilide hydroxamic acid (SAHA, vorinostat) show considerable limitations. SAHA is a histone deacetylase (HDAC) inhibitor that can cause undesirable side effects due to the lack of se...
Autores principales: | Zhang, Issan, Beus, Maja, Stochaj, Ursula, Le, Phuong Uyen, Zorc, Branka, Rajić, Zrinka, Petrecca, Kevin, Maysinger, Dusica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158288/ https://www.ncbi.nlm.nih.gov/pubmed/30302275 http://dx.doi.org/10.1038/s41420-018-0103-0 |
Ejemplares similares
-
SAHAquines, Novel Hybrids Based on SAHA and Primaquine Motifs, as Potential Cytostatic and Antiplasmodial Agents
por: Beus, Maja, et al.
Publicado: (2018) -
Primaquine derivatives: Modifications of the terminal amino group
por: Zorc, Branka, et al.
Publicado: (2019) -
Primaquine and Chloroquine Fumardiamides as Promising Antiplasmodial Agents
por: Beus, Maja, et al.
Publicado: (2019) -
Itaconic acid hybrids as potential anticancer agents
por: Perković, Ivana, et al.
Publicado: (2020) -
Asymmetric Primaquine and Halogenaniline Fumardiamides as Novel Biologically Active Michael Acceptors
por: Rajić, Zrinka, et al.
Publicado: (2018)